Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the B-type receptor of interleukin 8 and/or to a pacap type 1 receptor

Details for Australian Patent Application No. 2005224123 (hide)

Owner Galderma Research & Development, S.N.C.

Inventors Safonova, Irina; Dolfi, Fabrizio

Agent Griffith Hack

Pub. Number AU-A-2005224123

PCT Pub. Number WO2005/089750

Priority 0401721 20.02.04 FR

Filing date 17 February 2005

Wipo publication date 29 September 2005

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/4164 (2006.01) - 1,3-Diazoles

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/089750 Priority application(s): WO2005/089750

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224124-Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation

2005224122-Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous vascularisation disorder